Loading company…
Netherlands-based company researching microRNAs as biomarkers for cardiovascular disease and offering heart disease diagnostic tests.
Mirnext B.V. was founded in 2012 and is based in Hilversum, Netherlands. The company researches and develops microRNAs as new biomarkers for cardiovascular disease. It also offers tests for the diagnostic routine and clinical management of patients with heart disease, and it is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in